S&P 500 Healthcare Sector SEC Filings — May 12, 2026

12-05-2026

Pacira BioSciences, Inc. issued a letter via DEFA14A filing urging stockholders to vote 'FOR' its three highly qualified board nominees—Christopher Christie, Samit Hirawat, MD, and Thomas Wiggans—using the BLUE proxy card at the June 9, 2026 Annual Meeting, highlighting their expertise in biopharma leadership, M&A, R&D, and the 5x30 strategy for sustainable growth. The company criticizes activist investor DOMA Perpetual Capital Management LLC's nominees—Oliver Benton Curtis III, Eric de Armas, and Christopher Dennis—as underqualified, lacking biopharma experience and public board service, potentially leading to value destruction through cost cuts, pipeline discontinuation, and a rushed sale. Pacira notes 17 meetings with DOMA since September 2023 yielded no new insights, reaffirming its strategic path while warning against DOMA's disruptive campaign.

• · Stockholders of record as of April 22, 2026 are entitled to vote at the Annual Meeting.
• · Pacira board offered interviews to all DOMA nominees; two interviewed and deemed underqualified, Eric de Armas declined.
• · DOMA's proposed actions include broad cost cuts, discontinuing pipeline development, replacing CEO Frank D. Lee, and initiating an immediate sale process.

12-05-2026

Alpha Financial Advisors, LLC filed Form 13F-HR on May 12, 2026, disclosing its equity holdings as of March 31, 2026, totaling $326,381,492 across 62 positions held with sole investment discretion. The portfolio features significant allocations to Dimensional ETF Trust products (e.g., US Core Equity Market ETF, International Core Equity), alongside ETFs from Vanguard, iShares, American Century, Capital Group, and select individual stocks including Apple, Microsoft, NVIDIA, Alphabet, Amazon, Eli Lilly, and Berkshire Hathaway. No prior period data is provided in the filing for comparison.

• · Report period end date: 03-31-2026
• · Filing date: 05-12-2026
• · Date as of change: 05-11-2026
• · State of incorporation: NC
• · Business address: 11325 N Community House Rd. Suite 410, Charlotte, NC 28277
• · All holdings reported as sole investment discretion with no other managers

12-05-2026

Reyes Financial Architecture, Inc., a San Diego-based investment manager, filed its 13F-HR on May 12, 2026, disclosing equity holdings as of March 31, 2026, totaling $122,358,934,000 across 348 positions, all with sole voting power in most cases. Top holdings include Apple Inc. at $2,205,414,000, J P Morgan Exchange Traded F Equity Premium at $1,551,558,000, Meta Platforms Inc. Cl A at $1,843,975,000, and Broadcom Inc. at $1,236,897,000. No prior period data is available in the filing for comparison.

• · Filing covers period ending 2026-03-31.
• · All positions reported with sole shared power of 0 and other managers power of 0 except minor discrepancies (e.g., Apple: 8690 shares total, 8689 sole; Meta: 3223 shares total, 657 sole).

12-05-2026

GGM Financial LLC, an investment advisor based in Columbus, OH, filed its 13F-HR on May 12, 2026, reporting total holdings valued at $217,271,379 across 236 positions as of March 31, 2026. The portfolio is diversified with a heavy emphasis on ETFs, including top holdings like JPMorgan Active Growth ETF ($50,810,139) and Innovator Laddered Fund of S&P 500 Power Buffer ETF ($27,094,369). All positions are held solely with no shared voting or investment discretion reported.

• · Filing covers period ending 2026-03-31 with 0 discretionary accounts.
• · All holdings reported as SH SOLE with 0 voting/other rights.
• · Kent Keister signed as Chief Compliance Officer on 2026-05-11.

12-05-2026

Circle Wealth Management, LLC disclosed $7,015,622,120 in equity holdings across 266 positions in its 13F-HR filing as of March 31, 2026. The portfolio is heavily concentrated in Apple Inc. ($3,031,393,087; 11,944,494 shares), representing over 43% of total value, with additional significant positions in broad-market ETFs including iShares Core S&P 500 ETF ($711,278,956), iShares Russell 1000 Growth ETF ($581,384,887), and SPDR S&P 500 ETF ($539,944,085). Minor put positions were reported in Apple, Merck & Co., and SPDR S&P 500, but no period-over-period changes are available in this snapshot filing.

• · Filing date: May 12, 2026
• · Report period end date: March 31, 2026
• · Filer CIK: 0001578242
• · Business address: 47 Maple Street, Suite 201, Summit, NJ 07901
• · All positions held with sole voting authority

12-05-2026

Second Half Financial Partners, LLC filed its 13F-HR report on May 12, 2026, disclosing 96 equity positions with a total market value of $222104570 as of March 31, 2026, all held solely with discretionary voting authority. The portfolio features heavy ETF exposure, including top holdings SPDR Series Trust ($43007987), NEOS ETF Trust Nasdaq-100 High Income ($24820283), and NEOS ETF Trust S&P 500 High Income ($19985052), alongside stocks like Apple Inc. (12771 shares, $3241118) and Nvidia Corp. (10400 shares, $1813809). No prior period comparisons, changes, or performance data were provided.

• · All positions reported as SH SOLE with 0 shared voting authority
• · Filer CIK: 0001946654, EIN: 854341638, incorporated in FL
• · Business address: 145 West Center Avenue, Sebring, FL 33870

12-05-2026

Matthew 25 Management Corp filed its 13F-HR on May 12, 2026, for the quarter ended March 31, 2026, disclosing holdings across 20 securities with sole voting authority and no put/call options. Largest positions include Nvidia Corp (376,000 shares valued at $65,574,400), Taiwan Semiconductor Manufacturing Co Ltd (98,000 shares at $33,119,100), and Eli Lilly & Co (27,500 shares at $25,293,675). Other notable holdings are Amazon.com (98,250 shares at $20,462,528), Apple Inc. (55,000 shares at $13,958,450), and Palantir Technologies Inc. (85,500 shares at $12,506,940).

• · Berkshire Hathaway Inc. Class A: 15 shares valued at $10,772,100
• · Federal Agric Mtg Corp CLA: 102,250 shares valued at $12,167,750
• · Park Hotels & Resorts Inc.: 882,500 shares valued at $9,292,725

12-05-2026

United Super Pty Ltd, as Trustee for the Construction & Building Unions Superannuation Fund, filed a 13F-HR on May 12, 2026, disclosing 185 equity positions totaling $5307293435 as of March 31, 2026. Top holdings by value include NVIDIA Corporation ($326959540, 1874768 shares), Amazon.com Inc ($305907393, 1468802 shares), Alphabet Inc Class A ($258179995, 897830 shares), Microsoft Corp ($236112935, 637850 shares), and Apple Inc ($236865761, 933314 shares). All positions are reported as sole ownership with no put or call options.

• · Filing date: May 12, 2026
• · Report period end: March 31, 2026
• · All holdings designated as SOLE with zero put and call options
• · Filer CIK: 0001730896
• · Business address: Level 22, 130 Lonsdale Street, Melbourne VIC 3000, Australia

12-05-2026

Womack Financial LLC filed its 13F-HR report disclosing total holdings valued at $135905990 across 71 positions as of March 31, 2026. The portfolio features heavy allocations to Schwab Strategic Trust ETFs, including the US Mid-Cap ETF at $15182536 (490392 shares), US Large-Cap Growth ETF at $10590475 (363559 shares), and US Small-Cap ETF at $6141244 (211184 shares), alongside individual stocks such as Apple Inc. ($2831050, 11155 shares) and Nvidia Corporation ($2096986, 12024 shares). No period-over-period changes are provided in this quarterly snapshot filing.

• · Filing date: May 12, 2026
• · Report period end: March 31, 2026
• · All holdings reported as sole voting authority (SH SOLE)

12-05-2026

Collier Financial filed its 13F-HR report disclosing 136 equity holdings totaling $131,124,583 in market value as of March 31, 2026. The portfolio features a diversified mix of individual stocks including Berkshire Hathaway Class A (1 share valued at $718,140), Apple Inc. (584 shares valued at $148,247), and Amazon.com (98 shares valued at $20,410), alongside significant positions in ETFs from State Street, iShares, Invesco, and others. No period-over-period comparisons or performance changes are provided in this snapshot filing.

• · Filing date: May 12, 2026
• · Report period end: March 31, 2026
• · Business address: 8055 E Tufts Ave, Suite 650, Denver, CO 80237
• · All holdings reported with sole voting authority (SOLE)

12-05-2026

For the three months ended March 31, 2026, New Mountain Net Lease Trust reported total revenues of $30,012, up 11% YoY from $27,051, driven by higher rental revenue, with net income rising 14% YoY to $5,999 and net cash from operating activities increasing 11% to $14,620. However, total expenses surged 27% YoY to $14,512, investments in real estate declined 0.7% QoQ to $1,285,495 from $1,294,008, and earnings per share decreased for Class F (to $0.11 from $0.12 YoY) and Class I (to $0.07 from $0.09 YoY). Total shareholders' equity grew 17% QoQ to $466,202, bolstered by $78,589 in common shares issued, while mortgage notes and credit facility decreased 7% QoQ to $862,943.

• · Earnings less than distributions worsened to ($145,181) as of March 31, 2026 from ($135,177) at December 31, 2025.
• · Distributions declared at $0.425 gross per share, totaling $14,646 paid.
• · Proceeds from common shares issued: $78,550 (net of offering costs).

12-05-2026

Bain Capital Specialty Finance, Inc. (BCSF) reported Q1 2026 net investment income of $27.4 million ($0.42 per share), down from $29.7 million ($0.46 per share) in Q4 2025, sufficient to cover the declared Q2 2026 dividend of $0.42 per share; however, net income fell sharply to $0.05 per share from $0.43 due to $24.0 million in net realized and unrealized losses. Net asset value per share declined to $16.86 from $17.23, while the investment portfolio fair value decreased to $2,470.8 million from $2,508.4 million, though non-accruals improved slightly to 1.4% (cost) and 0.6% (fair value). The company issued $350.0 million in 5.950% unsecured notes due 2031 and maintained a net debt-to-equity of 1.28x.

• · 92.6% of debt investments at fair value were floating rate as of Mar 31 2026.
• · Weighted average interest rate on debt outstanding was 4.6% for Q1 2026, flat QoQ.
• · Undrawn investment commitments totaled $442.6 million as of Mar 31 2026.

12-05-2026

Sound Financial Bancorp reported net income of $1,576 thousand for the three months ended March 31, 2026, up 35% YoY from $1,167 thousand, with net interest income increasing 12% to $9,047 thousand amid higher loan interest income. However, noninterest income fell 17% to $910 thousand due to lower service charges, BOLI earnings, and mortgage servicing income, while provision for credit losses flipped to an expense of $123 thousand from a $203 thousand release. Total assets grew 1.8% QoQ to $1,112,051 thousand as of March 31, 2026, driven by 1.8% loan portfolio growth and 2.1% deposit increase.

• · Earnings per share (basic and diluted): $0.61 for Q1 2026 vs. $0.45 for Q1 2025
• · Cash dividends paid: $0.21 per share in Q1 2026 (total $541 thousand) vs. $0.19 per share in Q1 2025 (total $487 thousand)
• · Net cash used in investing activities: $21,062 thousand in Q1 2026 vs. provided $13,919 thousand in Q1 2025, primarily due to $16,019 thousand net increase in loans
• · Allowance for credit losses on loans: $8,635 thousand as of March 31, 2026 (up from $8,605 thousand at Dec 31, 2025)

12-05-2026

Catalyst Financial Partners LLC filed its 13F-HR on May 12, 2026, disclosing $846,871,203 in total portfolio value as of March 31, 2026, across 370 holdings, primarily sole discretionary positions. Top holdings include iShares Core MSCI EAFE ETF at $73,003,231 (806,398 shares), Apple Inc. at $31,178,268 (122,851 shares), and Microsoft Corp. at $18,839,454 (50,894 shares). The portfolio features a diversified mix of large-cap stocks, ETFs, and sectors with no period-over-period changes reported in this filing.

• · All positions reported with sole voting and dispositive power (SH SOLE).
• · Business address: One Marina Park Drive, 16th Floor, Boston, MA 02210.
• · Phone: 617-239-8101.
• · SEC file number: 028-22739.
• · Conformed period of report: 03-31-2026.

12-05-2026

Silver Rock Financial LP filed its 13F-HR on May 12, 2026, for the period ending March 31, 2026, disclosing a total portfolio market value of $49,653,407 across 22 positions, primarily warrants in small-cap companies and equities with larger stakes in Echostar Corp Note ($22,727,565), Comcast Corp New Cl A ($17,556,165 for 611,500 shares), Optimum Communications Inc Cl A ($3,640,000 for 2,800,000 shares), and Community Health Sys Inc New Com ($3,234,000 for 1,100,000 shares). All reported holdings carry sole voting power with no shared voting or investment discretion indicated. No period-over-period changes or performance metrics are provided in the filing.

• · All holdings reported with sole voting power (SH SOLE) and zero shared voting, sole investment discretion, or other manager power.
• · Filer CIK: 0001674784, SEC file number: 028-17808.
• · Business address: 12100 Wilshire Boulevard, Suite 1000, Los Angeles, CA 90025.

12-05-2026

Godfrey Financial Associates, Inc. filed its 13F-HR report disclosing $116,526,256 in total market value across 1,122 positions as of March 31, 2026, all held with sole voting power. Top holdings include Berkshire Hathaway Inc. CL B ($1,606,278 for 3,352 shares), Alphabet Inc. CAP STK CL A ($1,359,881 for 4,729 shares), Amazon.com Inc. ($1,119,868 for 5,377 shares), Apple Inc. ($813,488 for 3,205 shares), and Arista Networks Inc. ($944,915 for 7,696 shares). No prior period comparisons or changes are provided in the filing.

• · Filing date: May 12, 2026
• · Report period end: March 31, 2026
• · All positions held with sole discretionary voting power (SH SOLE)

12-05-2026

News Corporation disclosed via 8-K information provided to the Australian Securities Exchange (ASX) regarding its stock repurchase program, under which it is authorized to acquire up to $1 billion aggregate of Class A (NWSA) and Class B (NWS) common stock. Exhibits 99.1 and 99.2 contain the specific ASX disclosures on the dates noted therein. The statements include forward-looking intent to repurchase shares, subject to market conditions and other factors.

• · Date of earliest event reported: May 11, 2026
• · Filing date: May 12, 2026
• · Securities: Class A Common Stock (NWSA), Class B Common Stock (NWS)

12-05-2026

Unicycive Therapeutics reported a net loss of $12,823 thousand for the three months ended March 31, 2026, compared to net income of $570 thousand in the prior year period, driven by a $4,780 thousand loss on change in fair value of warrant liability versus an $8,348 thousand gain last year, while total operating expenses rose 5.6% YoY to $8,437 thousand with G&A up 17% despite R&D down 26%. Cash and equivalents increased to $37,371 thousand from $29,198 thousand at year-end, supported by $19,569 thousand net financing proceeds, and operating cash use improved to $6,241 thousand from $8,903 thousand. Stockholders' equity grew to $37,704 thousand from $30,197 thousand, though accumulated deficit widened to $140,648 thousand.

• · Warrant liability increased to $21,695 thousand from $16,915 thousand.
• · Weighted-average basic shares outstanding: 23,908,153 for Q1 2026 vs 11,681,881 for Q1 2025.
• · Issuance of 3,123,537 common shares for $19,566 thousand net proceeds in Q1 2026.
• · Marketable securities increased to $17,215 thousand from $12,071 thousand.

12-05-2026

VPG reported Q1 FY2026 net revenues of $84.4 million, up 17.6% YoY from $71.7 million and 4.7% sequentially, with bookings of $102.1 million (up 25.5% sequentially) and a book-to-bill of 1.21 across strong segment performances including Sensors (+23.1% YoY revenue). However, operating margin was a low 0.4% (flat adjusted at 1.9% YoY), Weighing Solutions gross margin declined to 34.2% YoY from 37.8%, and Measurement Systems revenue fell 7.3% sequentially; net loss per share improved slightly to $(0.02) from $(0.07). Management anticipates Q2 FY2026 revenues of $85-90 million at constant FX.

• · Adjusted EBITDA margin of 7.0% in Q1 FY2026.
• · Q2 FY2026 net revenues guidance: $85M to $90M at constant Q1 FY2026 FX rates.
• · Revised non-GAAP definitions exclude share-based compensation expense starting FY2026.

12-05-2026

ProMIS Neurosciences reported Q1 2026 net loss of $8.2 million, an increase from $7.3 million in Q1 2025, reflecting higher expenses amid clinical progress. The company closed a PIPE financing with $75.5 million up-front proceeds and potential additional $100 million from warrants, for total gross proceeds up to $175 million, boosting cash to $63.8 million and extending runway through 2027. The PRECISE-AD Phase 1b trial for PMN310 is fully enrolled with 144 participants, with blinded interim analysis expected in early Q3 2026 and top-line data in early 2027.

• · PRECISE-AD trial includes three dosing cohorts: 5, 10, 20 mg/kg IV over 12 months.
• · PMN310 granted Fast Track designation by FDA in July 2025.
• · Trial NCT numbers: Phase 1a NCT06105528, PRECISE-AD NCT06750432.

12-05-2026

CalciMedica reported net income of $5.0 million ($0.31 basic per share) for Q1 2026 versus a $5.0 million net loss ($0.36 per share) in Q1 2025, driven by $10.6 million in other income from fair value adjustments, though operating loss was $5.6 million with R&D expenses down 17% YoY to $3.5 million and cash declining to $8.2 million (sufficient into Q4 2026). Clinical progress includes expected FDA feedback in 2Q 2026 on Auxora pivotal program in acute pancreatitis (AP) and potential AKI development, positive Phase 2b CARPO trial publications showing dose-dependent benefits including 100% reduction in new-onset severe respiratory failure (p<0.05), but enrollment paused in Phase 2 KOURAGE AKI trial with no drug-related toxicity identified. Preclinical work on oral CM5480 for pulmonary hypertension advances toward 2027 IND.

• · Total assets $8.6M as of March 31, 2026 vs $13.6M as of December 31, 2025.
• · High-dose Auxora achieved stratified win ratio of 1.640 (p<0.05) in CARPO trial hierarchical composite.
• · Preclinical data supports CRAC inhibition preserving anti-inflammatory pathways in T-cells.

12-05-2026

Harvard Bioscience, Inc. (HBIO) filed an 8-K on May 12, 2026, under Items 7.01 and 9.01, disclosing its current corporate slide presentation dated May 2026 as Exhibit 99.1. The presentation is distributed to the investment community at conferences to provide business updates and summaries. The information is not deemed 'filed' under Section 18 of the Exchange Act or incorporated by reference except as expressly set forth.

12-05-2026

Achieve Life Sciences closed a private placement of up to $354 million ($180 million upfront and $174 million in milestone warrants) to fund the ORCA-V2 Phase 3 trial, commercialization, and operations. The company appointed Andrew D. Goldberg, MD as CEO, added board members, and partnered with Adare Pharma Solutions for U.S. manufacturing amid a regulatory setback with an expected FDA Complete Response Letter by June 20, 2026 due to prior manufacturer issues, planning NDA resubmission in Q4 2026. Q1 2026 net loss improved to $10.2 million from $12.8 million YoY with lower R&D expenses, but G&A rose and cash fell to $29.3 million (excluding proceeds) from $36.4 million at year-end.

• · FDA PDUFA date June 20, 2026; expect Complete Response Letter due to prior manufacturer OAI classification (not cytisinicline-specific).
• · NDA resubmission planned for Q4 2026 with Adare as primary commercial manufacturer; U.S. launch targeted H1 2027.
• · Tom King last Board day June 8, 2026; Jaime Xinos transition effective May 31, 2026.
• · Conference call held May 12, 2026 at 8:30 AM EDT.

12-05-2026

Sagimet Biosciences reported Q1 2026 financial results with net loss of $10.7 million, improved from $18.2 million in Q1 2025, due to R&D expenses declining to $7.0 million from $15.3 million YoY, though G&A expenses ticked up slightly to $4.7 million from $4.5 million and cash position decreased to $104.5 million from $113.1 million at year-end 2025. The company completed a $175 million equity financing in April 2026, providing a cash runway through 2028 including Phase 3 data readout for denifanstat in acne. Plans include initiating the U.S. Phase 3 trial for denifanstat in moderate to severe acne and Phase 2 for TVB-3567 in H2 2026.

• · Key opinion leader event and webcast held on April 30, 2026.
• · Poster presentation on FASN inhibitors at 83rd Society for Investigative Dermatology Annual Meeting on May 15, 2026.
• · Weighted-average shares outstanding: 32,559,704 for Q1 2026 vs 32,195,345 for Q1 2025.
• · Net loss per share: ($0.33) for Q1 2026 vs ($0.56) for Q1 2025.

12-05-2026

ACCESS Newswire Inc. reported Q1 2026 revenue of $5.3M, down 3% YoY from $5.5M and 8% QoQ from $5.8M, with gross margin declining to 74% from 78% YoY due to lower revenue and higher distribution costs. However, average ARR per subscription customer increased to $12,803 from $11,139 YoY, total subscriptions rose to 1,119 with 180 new additions, cash flow from operations improved to $871,000 from $747,000 YoY, and Adjusted EBITDA remained flat at $564,000. Operating costs declined 6% YoY and customer subscription retention reached 92%.

• · GAAP net loss from continuing operations improved to $611,000 ($0.16 per diluted share) in Q1 2026 from $765,000 ($0.20 per diluted share) in Q1 2025.
• · Non-GAAP net income from continuing operations was $408,000 ($0.11 per diluted share) in Q1 2026 vs $206,000 ($0.05 per diluted share) in Q1 2025.
• · Adjusted free cash flow was approximately $1.0M in both Q1 2026 ($952,000) and Q1 2025 ($967,000).

12-05-2026

Corebridge Financial, Inc. and Equitable Holdings, Inc. issued a joint press release on May 12, 2026, announcing the proposed leadership team for Mountain Holding, Inc. (HoldCo), the parent entity in their previously announced all-stock merger agreement dated March 26, 2026. The filing incorporates the press release as Exhibit 99.1 under Items 8.01 and 9.01. No financial metrics or performance data were disclosed.

• · Merger agreement entered into on March 26, 2026.
• · Press release dated May 12, 2026, attached as Exhibit 99.1.
• · Filing pursuant to Rule 425 under the Securities Act.

12-05-2026

CIBC Asset Management Inc filed its 13F-HR report on May 12, 2026, disclosing 1,372 equity holdings totaling $40,917,592,531 as of March 31, 2026. Top positions include Apple Inc at $1,325,100,806 (5,222,142 shares), Bank of Montreal at $920,482,300 (6,780,318 shares), and Agnico Eagle Mines Ltd at $884,940,761 (4,358,701 shares), with significant allocations to technology (e.g., Alphabet Inc Cl A and Cl C, Amazon.com Inc) and Canadian financials/mining firms. No prior period data is provided in the filing for comparison.

• · Report filed under SEC file number 028-03663
• · Business address: 81 Bay Street, 20th Floor, Toronto, A6 M5J 0E7
• · Holdings primarily sole discretionary with minor put options on select positions (e.g., 2,605 puts on Apple Inc)

12-05-2026

PROCACCIANTI HOTEL REIT, INC., through its subsidiary PHR TCI LLC, entered into a Change in Terms Agreement dated May 6, 2026, with Beacon Bank & Trust, reducing the interest rate on a $15,600,000.00 loan (original promissory note dated June 6, 2024) to 6.50% through maturity on June 6, 2027. The loan balance remains at $15,600,000.00 and is secured by a commercial mortgage on property at 263 W Grandview Parkway, Traverse City, MI 49684, and all business assets of PHR TCI LLC. No other terms were modified.

• · Original promissory note dated June 6, 2024
• · Collateral: Commercial Mortgage and Assignment of Leases and Rents on 263 W Grandview Parkway, Traverse City, MI 49684, and all business assets of PHR TCI LLC

12-05-2026

Zeo ScientifiX, Inc. (ZEO) announced a significant milestone, achieving unaudited sales surpassing $1 million for the first time in company history during April 2026. The announcement was made via a press release on May 12, 2026, filed as Exhibit 99.1.

• · Filing date: May 12, 2026
• · Date of earliest event reported: May 12, 2026

12-05-2026

CB Financial Services, Inc. (CBFV) reported robust Q1 2026 net income of $3,867 thousand, more than doubling YoY from $1,909 thousand (+103%), fueled by net interest income growth to $13,872 thousand (+23% YoY) and lower interest expense. Total assets expanded 2.3% QoQ to $1,583,292 thousand, with deposits rising 2.7% QoQ to $1,375,437 thousand. However, net loans declined 0.4% QoQ to $1,147,534 thousand, provisions for credit losses on loans increased to $228 thousand from $68 thousand YoY, and comprehensive income fell to $2,364 thousand from $3,774 thousand YoY due to unrealized securities losses.

• · Provision for credit losses on loans increased to $228 thousand in Q1 2026 from $68 thousand in Q1 2025.
• · Dividends paid at $0.28 per share in Q1 2026 (vs $0.25 in Q1 2025), totaling $1,411 thousand.
• · Treasury stock purchased: 8,553 shares for $292 thousand in Q1 2026.
• · Weighted average basic shares outstanding: 5,053,586 in Q1 2026 (down from 5,125,577 in Q1 2025).
• · Net cash used in investing activities: $13,432 thousand in Q1 2026 (vs provided $13,181 thousand in Q1 2025).

12-05-2026

Cannon Financial Strategists, Inc. filed its 13F-HR report disclosing 109 investment positions with a total market value of $760793759 as of March 31, 2026. The portfolio is diversified across ETFs (e.g., Dimensional International Core Equity Market ETF at $122773023, American Century US Large Cap Value ETF at $91098238) and individual stocks (e.g., Apple Inc. at $1130106, Microsoft at $939053), with all holdings reported as sole ownership. No period-over-period changes are discernible from this single filing snapshot.

• · Report period end date: 03-31-2026
• · Filing date: 05-12-2026
• · Filer CIK: 0002031123
• · Filer address: 649-8 South Milledge Ave, Athens, GA 30605
• · All 109 positions held with sole voting and investment discretion

12-05-2026

Disciplined Investors, L.L.C. disclosed its Q1 2026 13F-HR holdings as of March 31, 2026, reporting a total portfolio market value of $167,975,056,000 across 139 positions, all held under sole discretion. The portfolio is heavily weighted toward ETFs, with top holdings including iShares International Select Dividend ETF ($12,910,880,000), Schwab U.S. Broad Market ETF ($8,359,747,000), and Dimensional U.S. Small Cap Value ETF ($5,004,869,000). No prior period data or changes are provided in this routine quarterly filing.

• · Filing date: May 12, 2026
• · Report period end date: March 31, 2026
• · All 139 holdings reported as SH SOLE (sole voting authority) with zero put/call options

12-05-2026

Mission Financial Group, LLC filed its 13F-HR on May 12, 2026, disclosing $108,311,193 in total portfolio value across 146 holdings as of March 31, 2025. Top positions include PIMCO Enhanced Short Maturity Active ETF ($7,443,987), Vanguard Total Stock Market ETF ($6,796,656), Apple Inc. ($4,319,553), T. Rowe Price Ultra Short Term ETF ($3,868,086), and First Trust FT Vest Gold ETF ($3,545,857), reflecting diversification into fixed income ETFs, broad equities, tech stocks, and precious metals. No period-over-period changes are provided in the filing.

• · Report period end date: March 31, 2025
• · Filing CIK: 0002113810
• · State of incorporation: NV
• · Business phone: 8084459965

12-05-2026

BNP Paribas Financial Markets filed its 13F-HR on May 12, 2026, disclosing U.S. equity and options holdings as of March 31, 2026. Key positions include American Express Company equity valued at $409764514 (1354683 shares), 3M Co at $109386800 (753197 shares), AMETEK Inc at $104041341 (485358 shares), ARK Innovation ETF at $56606557 (837499 shares), and ARM Holdings PLC at $36385866 (240520 shares). The filing lists numerous additional smaller holdings and substantial options positions on American Express Company, ARK Innovation ETF, and ARM Holdings PLC.

• · Filing period end date: March 31, 2026
• · SEC file number: 028-10038
• · Business address: 20 Boulevard des Italiens, Paris I0 75009
• · Numerous call and put options positions on American Express Company, ARK Innovation ETF, and ARM Holdings PLC

12-05-2026

Alerus Financial NA filed its 13F-HR on May 12, 2026, disclosing U.S. equity holdings as of March 31, 2026, with significant positions across technology, energy, and ETFs. Notable holdings include Dimensional ETF Trust World ex-US Core Equity ETF ($285.9B market value, 8,415,163 shares), Apple Inc. ($47.3B, 186,327 shares), Broadcom Inc. ($36.1B, 116,661 shares), Alphabet Inc. Class A ($33.5B, 116,527 shares), and Exxon Mobil Corp. ($20.7B, 121,871 shares). The filing lists approximately 515 positions, primarily held solely, with no prior period data provided for comparisons.

• · Filing period end date: March 31, 2026
• · SEC file number: 028-03439
• · Alerus Finl Corp sole holding: 142,043 shares valued at $3,367,839,000
• · Contact phone: 701-280-5032

12-05-2026

Frisco Financial Planning LLC, a Texas-based investment advisor, filed its Form 13F-HR on May 12, 2026, disclosing 26 equity holdings as of September 30, 2025, all held with sole voting authority. Notable positions include Schwab US Large-Cap ETF (442,046 shares valued at $11,643M), Schwab US Small-Cap ETF (124,095 shares valued at $3,462M), and Vanguard FTSE Developed Markets ETF (203,976 shares valued at $1,222M). No prior period comparisons or changes in holdings were detailed in the filing.

• · Filing period end date: September 30, 2025
• · All 26 positions held as SOLE shared voting authority with 0 other managers
• · Business address: 4737 Parkside Drive, Frisco, TX 75034
• · SEC file number: 028-26891
• · CIK: 0002133972

12-05-2026

Investor's Fiduciary Advisor Network, LLC filed its 13F-HR on May 12, 2026, disclosing U.S. equity and ETF holdings as of March 31, 2026, totaling $326.4 million across 270 positions, all held with sole discretionary voting and investment power. Top holdings include Apple Inc. ($14.65 million, 57,728 shares), Schwab Strategic Trust - U.S. Dividend Equity ETF ($13.36 million, 435,304 shares), and Microsoft Corp. ($12.73 million, 34,394 shares). The portfolio shows no reported changes or performance metrics in this filing.

• · All positions reported with sole shared investment discretion and sole voting power.
• · Firm address: 7829 Center Blvd., SE #304, Snoqualmie, WA 98065.
• · No other managers or shared discretion reported.

12-05-2026

MILLBANK DARTMOOR PORTSMOUTH LLC filed a 13F-HR report on May 12, 2026, disclosing its holdings as of March 31, 2026, with a total portfolio value of $153,730,541 across two positions held solely. The largest holding is 229,402 shares of State Street SPDR S&P 500 ETF Trust valued at $149,189,297, while the smaller position is 118,200 shares of iShares Bitcoin Trust ETF valued at $4,541,244.

• · Report filed under SEC file number 028-26228
• · Adviser CIK: 0002098560
• · Business address: 22 South Pack Sq, Asheville, NC 28801

12-05-2026

Ausdal Financial Partners, Inc. filed a 13F-HR combination report on May 12, 2026, disclosing institutional equity holdings as of March 31, 2026, with a total portfolio market value of $2,250,429,842 across 1,688 positions. Key holdings include Apple Inc. COM (187,539 shares SOLE valued at $47,595,444), Amazon.com Inc. COM (73,084 shares SOLE at $15,221,180), and Alphabet Inc. CAP STK CL A (43,436 shares SOLE at $12,490,535) and CL C (41,669 shares SOLE at $11,953,232). The filing covers affiliated managers such as Advyzon Investment Management, LLC, with no prior period comparisons provided.

• · Report filed under SEC file number 028-17378 as a combination report.
• · Business address: 5187 Utica Ridge Rd, Davenport, IA 52807.
• · Includes both SOLE and OTR voting authority positions across various stocks, ETFs, and options.

12-05-2026

Bread Financial Holdings, Inc. designated a new series of preferred stock, the 8.875% Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B, authorizing up to 138,000 shares with a $0.01 par value and $1,000 liquidation preference per share, for a total potential liquidation value of $138M. The series offers non-cumulative quarterly dividends at a fixed rate of 8.875% per annum from issuance until the First Reset Date of December 15, 2031, after which the rate resets to the Five-Year U.S. Treasury Rate plus 4.804%. Approvals were obtained via Board consent on May 4, 2026, and Pricing Committee consent on May 5, 2026, with the certificate effective May 12, 2026.

• · First dividend payment date: September 15, 2026.
• · Quarterly dividend payment dates: March 15, June 15, September 15, December 15.
• · Series B ranks senior to common stock and Series B Junior Securities, parity with Series A and other Series B Parity Securities.
• · Shares rank junior to existing or future indebtedness upon liquidation.

12-05-2026

Coyle Financial Counsel LLC filed its 13F-HR on May 12, 2026, reporting holdings as of March 31, 2026, with a total portfolio value of $472797325 across 113 positions held with sole voting power. The portfolio is diversified across ETFs and individual stocks, with top holdings including iShares Core S&P 500 ETF ($78135960), Vanguard Tax-Managed FDS VAN FTSE DEV MKT ($63822480), and Fidelity Merrimack STR TR Total BD ETF ($36258521). No prior period data is provided in the filing for comparison.

• · All 113 positions held with sole voting power (SH SOLE); no shared or other discretion reported.
• · Investment adviser CIK: 0001593038; SEC file number: 028-16084.

12-05-2026

Royce & Associates LP, listed as an Other Manager Reporting for Franklin Resources Inc., filed its 13F-HR combination report on May 12, 2026, covering holdings as of March 31, 2026, with a total portfolio market value of $10.13 billion across 774 positions focused on small-cap stocks. Top holdings include Arcosa Inc ($132.92M), Advance Auto Parts Inc ($64.56M), Cohu Inc ($62.09M), Academy Sports & Outdoors Inc ($58.77M), and Cirrus Logic Inc ($72.77M). All positions are reported with sole voting and shared power.

• · Historical context: Royce transitioned to reporting under Franklin Resources following the 2020 acquisition of Legg Mason.
• · All holdings designated as SH SOLE with 0 shared voting power and 0 other.
• · Business address: One Madison Avenue, New York, NY 10010.

12-05-2026

Orcam Financial Group filed its 13F-HR on May 12, 2026, disclosing total holdings of $140850233 across 62 positions as of March 31, 2026. The portfolio is dominated by ETFs, with the top holding Alpha Architect ETF TR Discipline Fund valued at $43449040, followed by Vanguard Intl Equity Index F TT Wrld St ETF at $12865627 and Schwab Strategic TR US Brd Mkt ETF at $7807182. Notable equity positions include Microsoft Corp ($235432, 636 shares), Amazon Com Inc ($291786, 1401 shares), and Apple Inc ($490478, 1933 shares), with no prior period comparisons or performance changes provided.

• · Report period end date: 2026-03-31
• · Filing as of date: 2026-05-12
• · Business address: 433 Union St, Encinitas, CA 92024
• · Business phone: 8582205383
• · SEC file number: 028-21688